IceCure Medical Ltd. announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application titled Cryogen Pump. The patent will be in effect until February 2040 and was recently granted in the European Union and allowed in Japan. The novel cryogenic pump enables the company to bring to market a new generation of cryoablation systems with a small footprint for a wide range of clinical applications.

Moreover, this pump expands the company 's portfolio of products with a broader range of thinner cryoprobes and catheters. The company 's novel cryogenic pump is submersible in liquid nitrogen, works in a closed circuit, enables temperature control of the cryoprobe, improves the cooling rate during a procedure, and is designed to be used for multiple procedures or longer duration procedures without the need to refill liquid nitrogen.